Lead party: International Finance Corporation (IFC) (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Aspen Pharmacare Holdings Limited (public company) · Sector: Healthcare, Pharmaceuticals, Medical Supplies, Biotechnology · Countries of operation: Mauritius, Uganda, Nigeria, Kenya, Tanzania, Namibia, Botswana, South Africa, Ghana
Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Syndicated Loan · Round: Growth Capital · Deal amount: US$553.3m
Investors/buyers: International Finance Corporation (IFC), Proparco, Deutsche Investitions-und Entwicklungsgesellschaft (DEG), The United States International Development Finance Corporation (DFC)
Legal advisers: not identified in the source record.
Source: announced 3 September 2024. Original announcement: ifc.org.


